Pharmafile Logo
Pharmafocus logo
Advanced Search

antimicrobial resistance

Showing 15 posts of 22 posts found.

towfiqu-barbhuiya-hn2hqoalbck-unsplash_1

European Parliament shares goal to tackle antimicrobial resistance

June 2, 2023
Medical Communications EU, European Parliament, Microbiology, antimicrobial resistance

The European Parliament has shared its recommendations for a “coordinated EU response to health threats posed by antimicrobial resistance,” according …

News

Is Pharma doing enough on sustainability?

July 20, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antimicrobial resistance, manufacturing, pharma, sustainability

Adoption of sustainable practices in pharmaceutical operations is ticking along, but given the environmental and health risks if this is …

Feature
shutterstock_gonnorrhea

Industry comes together to form the AMR Action Fund, pledging $1bn to fight antimicrobial resistance

July 10, 2020
Medical Communications, Research and Development AMR, antimicrobial resistance, biotech, pharma

Over 20 biopharma firms have come together to launch the AMR Action Fund, an initiative of the International Federation of …

News
antibiotic-resistance-pill-running-from-bacteria-1500

The global rise in antibiotic resistance threatens infection prevention and cure

May 20, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance, antimicrobial resistance, feature, pharma

Dr Bill Love, Founder and Chief Scientific Officer of Destiny Pharma, discusses the rise of antimicrobial resistance (AMR), the antibiotic …

Feature

AMR advisor calls for public utility company to tackle AMR

March 28, 2019
Medical Communications, Research and Development AMR, Lord Jim O'Neill, antimicrobial resistance, pharma, public health

Lord Jim O’Neill, an economist and former government advisor on antimicrobial resistance (AMR), has accused the pharmaceutical industry of “spewing …

News
shutterstock_168864905

Destiny Pharma secures £1.6m grant to fight ‘superbugs’ and antimicrobial resistance

January 29, 2019
Manufacturing and Production, Research and Development Destiny Pharma, antimicrobial resistance, pharma

UK biotech Destiny Pharma has secured £1.6 million in funding to further its research into the prevention and elimination of …

News
staphylococcus_aureus_visa

AMR superbugs expected to kill 90,000 Britons in the next 30 years

November 8, 2018
Research and Development AMR, antimicrobial resistance, infectious diseases, spanish flu

Antibiotic resistant superbugs will kill more than 90,000 British people over the next thirty years if action is not taken …

News
cow_field_farm_nature_agriculture_green_meadow_animal-1278036

UK government accused of using Brexit to avoid antimicrobial resistance ruling

September 28, 2018
Medical Communications AMR, Antibiotics, UK, WHO, antimicrobial resistance, farming, politics

The British government has been accused of using Brexit to avoid implementing new EU legislation preventing powerful antibiotics from be …

News
donald_trump_29496131773

Trump administration resists WHO efforts to tackle antimicrobial resistance

August 31, 2018
Medical Communications AMR, Trump, US, US government, WHO, antimicrobial resistance

The Trump administration is in the process of drafting an alternative to the World Health Organization’s guidelines on the use …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, China, GSK, Gilead, J&J, JJ, Pfizer, Remicade, Roche, antimicrobial resistance, biosimilar, pharma, pricing, viagra

With the UK in the grip of a record-breaking heatwave, it’s hard to focus on much else over here, but …

News
512px-antibiotic_sensitvity_and_resistance

The mission against antimicrobial resistance

July 23, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance, antimicrobial resistance, feature, pharma

Two headlines have highlighted the ‘here and now’ of the threat of rising antimicrobial resistance (AMR), writes Dr Peter Jackson.A …

Feature

NICE calls to limit antibiotic use in COPD over antimicrobial resistance fears

July 10, 2018
Manufacturing and Production, Medical Communications, Research and Development COPD, NICE, antimicrobial resistance, chronic obstructive pulmonary disease, pharma

NICE have published a draft antimicrobial prescribing guide recommending that healthcare professionals should consider the risk of antimicrobial resistance when …

News
india-coor-locator

64% of FDC antibiotics in India are unapproved, report reveals

February 5, 2018
Manufacturing and Production, Sales and Marketing Antibiotics, India, antimicrobial resistance, pharma

The majority of fixed dose combination (FDC) antibiotics that are made and sold in India are still unapproved, despite promises …

News

Pfizer teams up with Indian Government to battle antimicrobial resistance

January 31, 2018
Medical Communications, Research and Development India, Pfizer, antimicrobial resistance, pharma

Pfizer has entered into a partnership with the Indian Council of Medical Research (ICMR) in an effort to fight antimicrobial …

News
world_health_organization

Antibiotic development is inadequate to meet global resistance threat, WHO warns

September 20, 2017
Research and Development WHO, antibiotic resistance, antimicrobial resistance, pharma, pharmaceutical, world health organization

The World Health Organization (WHO) has released a report indicating that worldwide development of new antibiotics is not keeping pace …

News

Latest content

BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance

September 28, 2023

Avalyn Pharma raises $175m in Series C financing for inhalation therapies

September 28, 2023

NMD Pharma begins phase 2 trial for spinal muscular atrophy treatment

September 27, 2023

Alfasigma to acquire Intercept Pharmaceuticals for $19 per share

September 27, 2023

Regeneron and Sanofi’s sBLA for Dupixent accepted by FDA for priority review

September 26, 2023